MU
35
3
HST
58
11
LUV
39
-5
EQT
30
-9
HRL
27
-3
CHD
42
-3
CINF
37
6
AMAT
40
-3
O
35
5
NKE
28
-2
EOG
51
2
LEG
28
6
STX
52
2
NWSA
73
15
NWL
54
-2
LYB
37
12
GRMN
68
-2
DGX
33
-6
HAL
50
3
USB
44
-2
MU
35
3
HST
58
11
LUV
39
-5
EQT
30
-9
HRL
27
-3
CHD
42
-3
CINF
37
6
AMAT
40
-3
O
35
5
NKE
28
-2
EOG
51
2
LEG
28
6
STX
52
2
NWSA
73
15
NWL
54
-2
LYB
37
12
GRMN
68
-2
DGX
33
-6
HAL
50
3
USB
44
-2
Financhill
Back

Mereo BioPharma Group PLC 10K Form

Sell
50

MREO
Mereo BioPharma Group PLC

Last Price:
4.03
Seasonality Move:
9.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MREO News And Ratings

See the #1 stock for the next 7 days that we like better than MREO

MREO Financial Statistics

Sales & Book Value

Annual Sales: $10M
Cash Flow: $-7.9M
Price / Cash Flow: 0
Annual Sales: $0.51
Price / Book: 7.84

Profitability

EPS (TTM): -0.26390
Net Income (TTM): $-35.03M
Gross Margin: $7.43M
Return on Equity: 0%
Return on Assets: 0%

Mereo BioPharma Group PLC Earnings Forecast

Key Mereo BioPharma Group PLC Financial Ratios

  • The Gross Profit Margin over the past 7 years for MREO is 74.26%.
  • The Selling, General & Administrative Expenses for MREO have been equal to 184.24% of Gross Profit Margin.
  • The Research & Development expenses have been 174.18% of Revenue.
  • The Interest Expense is -9.78% of Operating Income.
  • The Net Earning history of MREO is -294.66% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Mereo BioPharma Group PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MREO
CUSIP: 589492
Website: mereobiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MREO Technical Analysis vs Fundamental Analysis

Sell
50
Mereo BioPharma Group PLC (MREO) is a Sell

Is Mereo BioPharma Group PLC a Buy or a Sell?